Since the beginning of 2026, shares of CRISPR Therapeutics (CRSP) are down by about 11%. While that’s not a great start to ...

Milestone Pharmaceuticals (NASDAQ:MIST) executives highlighted the company’s transition to commercialization during a ...

An inability to satisfy ratio or incurrence-based tests in leveraged finance loan agreements can lead to a borrower group being unable to draw debt ...

Departing Disney CEO Bob Iger delivered a farewell address at the 2026 shareholders meeting as he welcomed Josh D'Amaro as ...

Workiva Inc. remains a compelling Buy trading at attractive valuations despite strong growth and robust fundamentals. Read ...

Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024Greenbrook clinic revenue of ...

Silvaco Group surged over 50% post-Q4 FY25 earnings last week, driven by strong TCAD bookings and explosive SIP revenue ...

Appeals to the government to work for a diplomatic solution are maintained even as it has made clear its commitment to the US-led war, making UK air bases available for American aircraft and deploying ...

With a new strategy, the European Council wants to make domestic tech corporations and mobile operators internationally competitive.

Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio –– Enables ...

Will McIntosh, Versant's president of digital platforms and ventures, shares his outlook for Fandango, Rotten Tomatoes and ...